Publications | Lund University Publications

41 – 50 of 127

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=issn+exact+%221078-0432%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
4
5
6
7
…
13
next »

2016
Mark Prognostic and chemotherapy predictive value of gene-expression phenotypes in primary lung adenocarcinoma.
Ringnér, Markus ^LU ; Jönsson, Göran B ^LU and Staaf, Johan ^LU (2016) In Clinical Cancer Research 22(1). p.218-229
- Contribution to journal › Article
Mark Leukemic stem cell quantification in newly diagnosed chronic myeloid leukemia patients predicts response to nilotinib therapy
Thielen, Noortje ; Richter, Johan ^LU ; Baldauf, Matthias ; Barbany, Gisela ; Fioretos, Thoas ^LU ; Giles, Francis ; Gjertsen, Bjørn Tore ; Hochhaus, Andreas ; Schuurhuis, Gerrit Jan and Sopper, Sieghart , et al. (2016) In Clinical Cancer Research 22(16). p.4030-4038
- Contribution to journal › Article
Mark Changes in expression of genes representing key biologic processes after neoadjuvant chemotherapy in breast cancer, and prognostic implications in residual disease
Klintman, Marie ^LU ; Buus, Richard ; Cheang, Maggie Chon U ; Sheri, Amna ; Smith, Ian E. and Dowsett, Mitch (2016) In Clinical Cancer Research 22(10). p.2405-2416
- Contribution to journal › Article
Mark A randomized phase II/III study of naptumomab estafenatox + IFNα versus IFNα in renal cell carcinoma : Final analysis with baseline biomarker subgroup and trend analysis
Hawkins, Robert E. ; Gore, Martin ; Shparyk, Yaroslav ; Bondar, Vladimir ; Gladkov, Oleg ; Ganev, Tosho ; Harza, Mihai ; Polenkov, Serhii ; Bondarenko, Igor and Karlov, Petr , et al. (2016) In Clinical Cancer Research 22(13). p.3172-3181
- Contribution to journal › Article
Mark A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort
Terry, Kathryn L ; Schock, Helena ; Fortner, Renée T ; Hüsing, Anika ; Fichorova, Raina N ; Yamamoto, Hidemi S ; Vitonis, Allison F ; Johnson, Theron ; Overvad, Kim and Tjønneland, Anne , et al. (2016) In Clinical Cancer Research 22(18). p.4575-4664
- Contribution to journal › Article
2015
Mark Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-based Prospective Cohort.
Elebro, Karin ^LU ; Borgquist, Signe ^LU ; Simonsson, Maria ^LU ; Markkula, Andrea ^LU ; Jirström, Karin ^LU ; Ingvar, Christian ^LU ; Rose, Carsten ^LU and Jernström, Helena ^LU (2015) In Clinical Cancer Research 21(16). p.3640-3650
- Contribution to journal › Article
Mark The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T cell dependent tumor immunity.
Mangsbo, Sara M ; Broos, Sissela ^LU ; Fletcher, Erika ; Veitonmaki, Niina ; Furebring, Christina ; Dahlen, Eva ; Norlén, Per ^LU ; Lindstedt, Malin ^LU ; Totterman, Thomas H and Ellmark, Peter ^LU (2015) In Clinical Cancer Research 21(5). p.1115-1126
- Contribution to journal › Article
Mark Caffeine and caffeic acid inhibit growth and modify estrogen receptor (ER) and insulin-like growth factor I receptor (IGF-IR) levels in human breast cancer.
Rosendahl, Ann ^LU ; Perks, Claire M ; Zeng, Li ; Markkula, Andrea ^LU ; Simonsson, Maria ^LU ; Rose, Carsten ^LU ; Ingvar, Christian ^LU ; Holly, Jeff Mp and Jernström, Helena ^LU (2015) In Clinical Cancer Research 21(8). p.1877-1887
- Contribution to journal › Article
Mark Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer
Candido-dos-Reis, Francisco J ; Song, Honglin ; Goode, Ellen L ; Cunningham, Julie M ; Fridley, Brooke L ; Larson, Melissa C ; Alsop, Kathryn ; Dicks, Ed ; Harrington, Patricia and Ramus, Susan J , et al. (2015) In Clinical Cancer Research 21(3). p.7-652
- Contribution to journal › Article
Mark A phase 1 dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma.
Hansson, Markus ^LU ; Gimsing, Peter ; Badros, Ashraf Z ; Martinsson Niskanen, Titti ; Nahi, Hareth ; Offner, Fritz ; Salomo, Morten ; Sonesson, Elisabeth ; Mau-Sorensen, Morten and Stenberg, Yvonne , et al. (2015) In Clinical Cancer Research 21(12). p.2730-2736
- Contribution to journal › Article

« previous
1
…
4
5
6
7
…
13
next »

your query:: Remove issn: 1078-0432